首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
【24h】

2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

机译:2016年美国风湿病学院/欧洲联盟对成人皮肤病和多发性肌炎的最小,中等和主要临床反应的风湿病标准,一种国际肌炎评估和临床研究组/儿科风湿病学国际试验组织合作倡议

获取原文
获取原文并翻译 | 示例
       

摘要

To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Expert surveys, logistic regression, and conjoint analysis were used to develop 287 definitions using core set measures. Myositis experts rated greater improvement among multiple pairwise scenarios in conjoint analysis surveys, where different levels of improvement in 2 core set measures were presented. The PAPRIKA (Potentially All Pairwise Rankings of All Possible Alternatives) method determined the relative weights of core set measures and conjoint analysis definitions. The performance characteristics of the definitions were evaluated on patient profiles using expert consensus (gold standard) and were validated using data from a clinical trial. The nominal group technique was used to reach consensus. Consensus was reached for a conjoint analysis-based continuous model using absolute per cent change in core set measures (physician, patient, and extramuscular global activity, muscle strength, Health Assessment Questionnaire, and muscle enzyme levels). A total improvement score (range 0-100), determined by summing scores for each core set measure, was based on improvement in and relative weight of each core set measure. Thresholds for minimal, moderate, and major improvement were >= 20, >= 40, and >= 60 points in the total improvement score. The same criteria were chosen for juvenile DM, with different improvement thresholds. Sensitivity and specificity in DM/ PM patient cohorts were 85% and 92%, 90% and 96%, and 92% and 98% for minimal, moderate, and major improvement, respectively. Definitions were validated in the clinical trial analysis for differentiating the physician rating of improvement (p< 0.001). The response criteria for adult DM/ PM consisted of the conjoint analysis model based on absolute per cent change in 6 core set measures, with thresholds for minimal, moderate, and major improvement.
机译:为成年皮肌炎(DM)和多发性肌炎(PM)制定响应标准。使用核心设定措施,使用专家调查,逻辑回归和联合分析来开发287个定义。 MyOSITIS专家在联合分析调查中的多个成对情景中额定改善,其中提出了2个核心设定措施的不同改进水平。辣椒粉(可能是所有可能替代方案的所有成对排名)方法确定了核心设定测量和联合分析定义的相对权重。使用专家共识(金标准)对患者谱进行定义的性能特征,并使用临床试验中的数据进行验证。标称组技术用于达成共识。使用核心设定措施(医生,患者和蛋白全球活动,肌肉力量,健康评估问卷和肌肉酶含量)的绝对百分比,达到基于联合分析的连续模型的共识。通过对每个核心设定测量的总和确定的总改进评分(范围0-100)是基于每个核心设定测量的改进和相对重量。最小,中等和重大改进的阈值> = 20,> = 40,> = = 60点,总改善得分。为少年DM选择相同的标准,具有不同的改进阈值。 DM / PM患者队列的敏感性和特异性分别为85%和92%,90%和96%,92%和98%,分别为最小,中等和重大改善。在临床试验分析中验证了定义,以区分改善的医生额定值(P <0.001)。成人DM / PM的响应标准包括基于6个核心设定措施的绝对百分比的联合分析模型,具有最小,中等和重大改进的阈值。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号